Cornerstone Therapeutics Inc. (NASDAQ:CRTX)
CAPS Rating:
A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response.
RSS Headlines
Fool UK
Recs
Asthma as a health problem is increasing and CRTX has solid offerings for treatment.